The Latest Breaking News from FDA

Recent banking turmoil and rising interest rates have weighed heavily on investors’ sentiment lately. However, weak economic data signaling slowing growth could result in relatively easy monetary policies in the second half of 2023. Given the macroeconomic backdrop, investors could consider adding fundamentally sound low P/E stocks Pfizer (PFE), Chevron…

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

At the age of 75, Peter Welch became one of the oldest freshmen to ever roam the Senate’s hallways after winning a vacated seat.

The rocky history of Evofem and Phexxi illuminates how big insurers and drugmakers are stifling innovation in women’s health.

New startups believe chatbot technology could help reduce the burden on physicians. But some academics warn bias and errors could hurt patients.

BALTIMORE — As soon as this summer, people will be able to purchase the opioid overdose reversal medication Narcan as easily as they can buy Tylenol and Benadryl, after the U.S. Food and Drug Administration approved it last week to be sold over the counter.

The Food and Drug Administration (FDA) on Tuesday warned consumers that three South Korean hair-dyeing products contain cancer-causing chemicals.

Washington state officials have purchased a three-year supply of a leading abortion medication in anticipation of a court ruling that could limit its availability

OLYMPIA, Wash. — Washington has stockpiled thousands of doses of an abortion pill in anticipation of a federal court ruling in Texas that could limit its availability, Gov. Jay Inslee said Tuesday.